Entourage Health Corp. (
TSX-V: ENTG)
(
OTCQX: ETRGF) (
FSE:4WE)
("
Entourage" or the "Company"), a Canadian
producer and distributor of award-winning cannabis products, is
pleased to announce the expansion of its medical portfolio with the
launch of a new CBD chewing gum available to Starseed
Medicinal patients on the Company’s medical platform.
Expanding medical services with enriched patient
care and new product offerings is reshaping how Canadians access
medical cannabis treatments, exemplifying Starseed’s commitment to
elevating the client experience. The Company has further developed
its medical product portfolio by launching a new CBD chewing gum
formulated to provide a rapid onset of CBD with 20 mg per unit (200
mg per pack). Cannabis-infused gum is made using CBD isolate in
partnership with NordicCan, a global leader in oral and intra-oral
delivery systems. The sugar-free gum is naturally flavoured with
eucalyptus-lemon-mint, providing a controlled release of
cannabinoids conveniently and discreetly.
Entourage is also pleased to announce it has
added a new union group to its full-service, proprietary medical
cannabis program in partnership with leading benefits
provider Union Benefits – the administrator of union group
benefits to over 12,000 members. The medical cannabis plan provides
eligible union members and their dependents access to practitioners
specializing in the authorization of medical cannabis as an insured
benefit. Additionally, Starseed provides a unique platform with no
co-pay or out-of-pocket insurance costs and is currently recognized
as one of the only medical cannabis programs in the world to offer
access to direct billing.
"Our commitment to developing innovative product
formulations has led us to engage with industry partners as part of
our ongoing commitment to meeting our patients’ changing and varied
needs. Introducing CBD chewing gum allows us to improve the patient
experience with a consistent pipeline of products," said George
Scorsis, CEO and Executive Chair. “We are proud to welcome our
newest member union to our full-service Starseed medical platform.
Through our partnership with Union Benefits, we are eliminating
barriers to members accessing medical cannabis as an alternative
therapy, educating patients, and providing responsible treatment
options."
More recently, Starseed increased its service
offerings by partnering with HelloMD’s virtual telehealth network
and now provides tailored patient treatment plans, plus resources
hosted on a virtual education platform.
Starseed currently offers over 45 products,
including cannabis-infused soft chews, transdermal patches, balms,
oils, capsules, vapes, and dried flower products. The Company has
partnered with Pineapple Express to provide same-day and
next-day delivery as an added convenience to patients residing
within select areas in Ontario. Visit our
website here and access our latest investor presentation and
corporate deck here.
For more information, please visit us
at www.entouragehealthcorp.com
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp. and CannTx Life Sciences
Inc., licence holders producing and distributing cannabis products
for both the medical and adult-use markets. The Company owns and
operates a state-of-the-art hybrid greenhouse and processing
facility located on 158-acres in Strathroy, ON; a fully licensed
26,000 sq. ft. Aylmer, ON processing facility. With its Starseed
Medicinal medical-centric brand, Entourage has expanded its
multi-channeled distribution strategy. Starseed’s industry-first,
exclusive partnership with LiUNA, the largest construction union in
Canada, along with employers and union groups complements
Entourage’s direct sales to medical patients. With the launch of
Syndicate, Entourage now hosts another unique medical marketplace
that offers patients a collective of Canadian micro-cultivators’
products, along with Entourage’s family of brands. Entourage’s
elite adult-use product portfolio includes Color Cannabis and
Saturday Cannabis – sold across eight provincial distribution
agencies. It is the exclusive Canadian producer and distributor of
award-winning U.S.-based wellness brand Mary’s Medicinals sold in
both medical and adult-use channels. Under a collaboration with The
Boston Beer Company subsidiary, Entourage is also the exclusive
distributor of cannabis-infused beverages ‘TeaPot’ in Canada,
which launched in summer 2022, starting in select provinces.
In addition, Entourage also entered into an exclusive agreement
with Irwin Naturals, a renowned nutraceutical and herbal supplement
formulator of popular branded wellness products sold across North
America. The new line of CBD soft gels is now available on
Starseed’s medical platform.
Follow Entourage and its brands
on LinkedIn
Twitter: Entourage, Color
Cannabis, Saturday Cannabis, Starseed
& Syndicate
Instagram: Entourage, Color
Cannabis, Saturday Cannabis, Starseed &
Syndicate
For Investor & Media
Enquiries:Catherine FlamanSenior Director, Communications
& Corporate
Affairs416-910-0279Catherine.flaman@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified using forward-looking
terminology such as "expect", "likely", "may", "will", "should",
"intend", "anticipate", "potential", "proposed", "estimate" and
other similar words, including negative and grammatical variations
thereof, or statements that certain events or conditions "may",
"would" or "will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions, and views of future events which management believes
to be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance, or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry in Canada generally; the
ability of Entourage to implement its business strategies; the
COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities' regulatory authorities on SEDAR
at www.sedar.com. The risk factors and other factors noted in
the disclosure documents could cause actual events or results to
differ materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024